Team Mobley

Expand to Read More +Collapse to Read Less –
Circuitry and Brain-Body Interactions | 2021

Reconstituting the Lost Nigrostriatal Circuitry in Parkinson’s Disease

Study Rationale: Team Mobley recently discovered that it is possible to generate new neurons to rebuild the damaged neural circuitries in a Parkinson’s disease model. This establishes a new foundation for developing strategies to reverse the disease. Team Mobley’s proposed project will investigate how to change a cell’s identity to encourage it to become a neuron, how to make the right new type of neurons in the brain to rebuild different circuitries, and how to make new neurons that will not become sick again.

Hypothesis: Team Mobley hypothesizes that astrocytes, an abundant population of non-neuronal cells in the brain, store a latent program that allows them to become neurons if the right types of inducing signals are provided.

Study Design: Team Mobley has designed five sets of experiments to address a series of fundamental questions on cell fate determination and reprogramming. The team will analyze individual cells to elucidate key regulatory events responsible for those cells to become neurons. Team Mobley will search for critical genes that make cell fate change less efficient so that the team can improve the reprogramming efficiency by inhibiting the function of those genes. The team will examine reprogramming in different brain regions to test their benefits to both motor and non-motor symptoms and develop strategies to make new and disease-resistant neurons.

Impact on Diagnosis: More information on cellular reprogramming will pave the way to rebuilding the neural circuitries lost to degeneration. If successful, this will lead to the development of a completely new cell replacement therapy against Parkinson’s disease.

Leadership
William Mobley, MD, PhD
Coordinating Lead PI

William Mobley, MD, PhD

University of California at San Diego
Xiang-Dong Fu, PhD
Co-Investigator

Xiang-Dong Fu, PhD

Westlake University
Steven Dowdy, PhD
Co-Investigator

Steven Dowdy, PhD

University of California at San Diego
Allen Wang, PhD
Co-Investigator

Allen Wang, PhD

University of California at San Diego
Yuanchao Xue, PhD
Co-Investigator

Yuanchao Xue, PhD

Chinese Academy of Sciences
Peter Shaw, PhD
Project Manager

Peter Shaw, PhD

University of California at San Diego

Project Outcomes

Team Mobley anticipates that their findings will establish the foundation for developing a cell replacement therapy for the disease based on the initial proof-of-concept study. Once fully developed, the team hopes to be able to effectively reverse the disease phenotype in PD patients. View Team Outcomes.

Team Outputs

Click the following icons to learn more about the team’s outputs

Overall Contributions

Updates will be posted when available.

Featured Output

The team is hard at work and will share outputs when available.

Team Accolades

  • Updates will be posted when available.

Other Team Activities

  • Working Groups: Senescence – Bill Mobley (Co-Chair)

In the News

Be a part of a global initiative to influence the culture of the way we do science.